DBV Technologies S.A. (DBVT) stock
DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
$11.43−0.45 (-3.79%)
Close on Nov 12, 2026Market cap $718.69MP/E –Yield –
DBV Technologies operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
DBV Technologies's operating cash flow for the twelve months ending Sep 30, 2026 was -$188.38M. For fiscal 2025 it was -$121.18M. The highest annual figure on record is -$55.67M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$121.18M | – |
| FY2024 | Dec 31, 2024 | -$104.47M | – |
| FY2023 | Dec 31, 2023 | -$79.65M | – |
| FY2022 | Dec 31, 2022 | -$55.67M | – |
| FY2021 | Dec 31, 2021 | -$108.24M | – |
| FY2020 | Dec 31, 2020 | -$165.61M | – |
| FY2019 | Dec 31, 2019 | -$148.35M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$51.50M | – |
| Q2 FY2026 | Jun 30, 2026 | -$52.60M | – |
| Q1 FY2026 | Mar 31, 2026 | -$49.10M | – |
| Q4 FY2025 | Dec 31, 2025 | -$35.18M | – |
| Q3 FY2025 | Sep 30, 2025 | -$32.40M | – |
| Q2 FY2025 | Jun 30, 2025 | -$33.90M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.70M | – |
| Q4 FY2024 | Dec 31, 2024 | -$12.25M | – |
| Q3 FY2024 | Sep 30, 2024 | -$22.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$35.07M | – |
| Q1 FY2024 | Mar 31, 2024 | -$34.69M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.69M | – |
| Q3 FY2023 | Sep 30, 2023 | -$19.57M | – |
| Q2 FY2023 | Jun 30, 2023 | -$25.55M | – |
| Q1 FY2023 | Mar 31, 2023 | -$20.84M | – |
| Q4 FY2022 | Dec 31, 2022 | -$23.89M | – |
| Q3 FY2022 | Sep 30, 2022 | -$20.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$10.25M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.48M | – |
| Q4 FY2021 | Dec 31, 2021 | -$18.79M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.95M | – |
| Q2 FY2021 | Jun 30, 2021 | -$30.30M | – |
| Q1 FY2021 | Mar 31, 2021 | -$36.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$33.53M | – |
| Q3 FY2020 | Sep 30, 2020 | -$42.23M | – |
| Q2 FY2020 | Jun 30, 2020 | -$40.17M | – |
| Q1 FY2020 | Mar 31, 2020 | -$49.68M | – |
See a number that looks wrong?